BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity (2011)
- Authors:
- USP affiliated authors: MORALES, ANDRESSA GOIS - IB ; HOJO, ELZA TIEMI SAKAMOTO - FFCLRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidades: IB; FFCLRP; FMRP
- DOI: 10.1097/cad.0b013e32834a16d4
- Subjects: OSTEOSSARCOMA (TRATAMENTO); FÁRMACOS; MITOSE
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2011
- Source:
- Título: Anti-Cancer Drugs
- ISSN: 0959-4973
- Volume/Número/Paginação/Ano: v. 22, n. 10, p. 995-1001, 2011
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MORALES, Andressa Gois et al. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity. Anti-Cancer Drugs, v. 22, n. 10, p. 995-1001, 2011Tradução . . Disponível em: https://doi.org/10.1097/cad.0b013e32834a16d4. Acesso em: 27 dez. 2025. -
APA
Morales, A. G., Brassesco, M. S., Pezuk, J. A., Oliveira, J. C. de, Montaldi, A. P., Hojo, E. T. S., et al. (2011). BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity. Anti-Cancer Drugs, 22( 10), 995-1001. doi:10.1097/cad.0b013e32834a16d4 -
NLM
Morales AG, Brassesco MS, Pezuk JA, Oliveira JC de, Montaldi AP, Hojo ETS, Scrideli CA, Tone LG. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity [Internet]. Anti-Cancer Drugs. 2011 ; 22( 10): 995-1001.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1097/cad.0b013e32834a16d4 -
Vancouver
Morales AG, Brassesco MS, Pezuk JA, Oliveira JC de, Montaldi AP, Hojo ETS, Scrideli CA, Tone LG. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity [Internet]. Anti-Cancer Drugs. 2011 ; 22( 10): 995-1001.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1097/cad.0b013e32834a16d4 - Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells
- MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells
- Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation
- Cytogenetic instability in childhood acute lymphoblastic leukemia survivors
- Low MIR-196B and high MIR-708 expression are associated with T-cell childhood acute lymphoblastic leukemia
- Characterization of LGALS3 (galectin-3) as a player in DNA damage response
- Silencing of checkpoint mitotic genes inhibits the proliferation and clonogenicity in pediatric glioblastoma cell line
- Cytostatic in vitro effects of DTCM-Glutarimide on bladder carcinoma cells
- In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors
- Effects of polo-like kinase 1 inhibition on glioblastoma cell lines
Informações sobre o DOI: 10.1097/cad.0b013e32834a16d4 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
